A Paradigm Shift To Prevent And Treat Alzheimers Disease
Download A Paradigm Shift To Prevent And Treat Alzheimers Disease full books in PDF, epub, and Kindle. Read online free A Paradigm Shift To Prevent And Treat Alzheimers Disease ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
| Author | : Howard Friel |
| Publisher | : Academic Press |
| Total Pages | : 292 |
| Release | : 2017-07-18 |
| Genre | : Science |
| ISBN | : 012812279X |
A Paradigm Shift to Prevent and Treat Alzheimer's Disease: From Monotargeting Pharmaceuticals to Pleiotropic Plant Polyphenols is the first book to systematically exhibit the powerful pleiotropic pharmacological effects on Alzheimer's disease of plant-based compounds from ancient foods that humans have been consuming safely with substantial health benefits for thousands of years. These plant-based compounds include curcuminoids from turmeric, resveratrol from red wine and grape seed extract from other grape products, epigallocatechin-gallate (EGCG) from green tea, and oleocanthal and oleuropein from olive oil, in addition to a special extract, EGb 761, from the leaves of Ginkgo biloba, the oldest living species of tree on earth. This book also presents a new analytical framework that convincingly favors a multi-targeting ("pleiotropic") approach to the prevention and treatment of complex chronic diseases, in contrast to the mono-targeting of the pharmaceutical model. A Paradigm Shift to Prevent and Treat Alzheimer's Disease is a unique and exciting resource for pharmaceutical scientists, pharmacologists, neurologists, general practitioners, research scientists in various medical and life sciences, healthcare professionals in clinical and executive positions, conventional medical schools, schools of naturopathic medicine, healthcare and medical journalists, executives in both national public healthcare systems and private insurers, and informed general readers. - Presents carefully compiled evidence supporting the need to shift from pharmaceutical-based mono-targeting to plant polyphenol-based pleiotropic targeting for the prevention and treatment of Alzheimer's disease - Includes valuable tables that aggregate pleiotropic pharmacological effects of the plant polyphenols on Alzheimer's disease-related pathogenic hallmarks - Highlights regulatory aspects and discusses the challenges and potential solutions with respect to bioavailability of certain plant polyphenols
| Author | : Dale Bredesen |
| Publisher | : Penguin |
| Total Pages | : 322 |
| Release | : 2017-08-22 |
| Genre | : Health & Fitness |
| ISBN | : 0735216207 |
The instant New York Times and Wall Street Journal bestseller A groundbreaking plan to prevent and reverse Alzheimer’s Disease that fundamentally changes how we understand cognitive decline. Everyone knows someone who has survived cancer, but until now no one knows anyone who has survived Alzheimer's Disease. In this paradigm shifting book, Dale Bredesen, MD, offers real hope to anyone looking to prevent and even reverse Alzheimer's Disease and cognitive decline. Revealing that AD is not one condition, as it is currently treated, but three, The End of Alzheimer’s outlines 36 metabolic factors (micronutrients, hormone levels, sleep) that can trigger "downsizing" in the brain. The protocol shows us how to rebalance these factors using lifestyle modifications like taking B12, eliminating gluten, or improving oral hygiene. The results are impressive. Of the first ten patients on the protocol, nine displayed significant improvement with 3-6 months; since then the protocol has yielded similar results with hundreds more. Now, The End of Alzheimer’s brings new hope to a broad audience of patients, caregivers, physicians, and treatment centers with a fascinating look inside the science and a complete step-by-step plan that fundamentally changes how we treat and even think about AD.
| Author | : Annette Leibing |
| Publisher | : Berghahn Books |
| Total Pages | : 268 |
| Release | : 2020-10-06 |
| Genre | : Medical |
| ISBN | : 1789209102 |
The conceptualization of dementia has changed dramatically in recent years with the claim that, through early detection and by controlling several risk factors, a prevention of dementia is possible. Although encouraging and providing hope against this feared condition, this claim is open to scrutiny. This volume looks at how this new conceptualization ignores many of the factors which influence a dementia sufferers’ prognosis, including their history with education, food and exercise as well as their living in different epistemic cultures. The central aim is to question the concept of prevention and analyze its impact on aging people and aging societies.
| Author | : Dale Bredesen |
| Publisher | : Penguin |
| Total Pages | : 354 |
| Release | : 2020-08-18 |
| Genre | : Health & Fitness |
| ISBN | : 052553850X |
The instant New York Times bestseller The New York Times Best Selling author of The End of Alzheimer's lays out a specific plan to help everyone prevent and reverse cognitive decline or simply maximize brainpower. In The End of Alzheimer's Dale Bredesen laid out the science behind his revolutionary new program that is the first to both prevent and reverse symptoms of Alzheimer's disease. Now he lays out the detailed program he uses with his own patients. Accessible and detailed, it can be tailored to anyone's needs and will enhance cognitive ability at any age. What we call Alzheimer's disease is actually a protective response to a wide variety of insults to the brain: inflammation, insulin resistance, toxins, infections, and inadequate levels of nutrients, hormones, and growth factors. Bredesen starts by having us figure out which of these insults we need to address and continues by laying out a personalized lifestyle plan. Focusing on the Ketoflex 12/3 Diet, which triggers ketosis and lets the brain restore itself with a minimum 12-hour fast, Dr. Bredesen drills down on restorative sleep, targeted supplementation, exercise, and brain training. He also examines the tricky question of toxic exposure and provides workarounds for many difficult problems. The takeaway is that we do not need to do the program perfectly but will see tremendous results if we can do it well enough. With inspiring stories from patients who have reversed cognitive decline and are now thriving, this book shifts the treatment paradigm and offers a new and effective way to enhance cognition as well as unprecedented hope to sufferers of this now no longer deadly disease.
| Author | : Hyun Kook Lim |
| Publisher | : Frontiers Media SA |
| Total Pages | : 99 |
| Release | : 2020-08-05 |
| Genre | : |
| ISBN | : 2889639177 |
| Author | : Judith Pratt |
| Publisher | : Springer |
| Total Pages | : 431 |
| Release | : 2019-01-05 |
| Genre | : Medical |
| ISBN | : 3319996428 |
This volume addresses one of the Holy Grails in Psychiatry, namely the evidence for and potential to adopt ‘Biomarkers’ for prevention, diagnosis, and treatment responses in mental health conditions. It meshes together state of the art research from international renowned pre-clinical and clinical scientists to illustrate how the fields of anxiety disorders, depression, psychotic disorders, and autism spectrum disorder have advanced in recent years.
| Author | : National Academies of Sciences, Engineering, and Medicine |
| Publisher | : National Academies Press |
| Total Pages | : 181 |
| Release | : 2017-10-05 |
| Genre | : Medical |
| ISBN | : 0309459591 |
Societies around the world are concerned about dementia and the other forms of cognitive impairment that affect many older adults. We now know that brain changes typically begin years before people show symptoms, which suggests a window of opportunity to prevent or delay the onset of these conditions. Emerging evidence that the prevalence of dementia is declining in high-income countries offers hope that public health interventions will be effective in preventing or delaying cognitive impairments. Until recently, the research and clinical communities have focused primarily on understanding and treating these conditions after they have developed. Thus, the evidence base on how to prevent or delay these conditions has been limited at best, despite the many claims of success made in popular media and advertising. Today, however, a growing body of prevention research is emerging. Preventing Cognitive Decline and Dementia: A Way Forward assesses the current state of knowledge on interventions to prevent cognitive decline and dementia, and informs future research in this area. This report provides recommendations of appropriate content for inclusion in public health messages from the National Institute on Aging.
| Author | : Dale Bredesen |
| Publisher | : Penguin |
| Total Pages | : 273 |
| Release | : 2021-08-17 |
| Genre | : Health & Fitness |
| ISBN | : 0593192427 |
First person stories of patients who recovered from Alzheimer's Disease--and how they did it. It has been said that everyone knows a cancer survivor, but no one has met an Alzheimer's survivor – until now. In his first two books, Dr. Dale Bredesen outlined the revolutionary treatments that are changing what had previously seemed like the inevitable outcome of cognitive decline and dementia. And in these moving narratives, you can hear directly from the first survivors of Alzheimer’s themselves--their own amazing stories of hope told in their own words. These first person accounts honestly detail the fear, struggle, and ultimate victory of each patient's journey. They vividly describe what it is like to have Alzheimer's. They also drill down on how each of these patients made the program work for them--the challenges, the workarounds, the encouraging results that are so motivating. Dr. Bredesen includes commentary following each story to help point readers to the tips and tricks that might help them as well. Dr. Bredesen's patients have not just survived; they have thrived to rediscover fulfilling lives, rewarding relationships, and meaningful work. This book will give unprecedented hope to patients and their families.
| Author | : Dennis J. Selkoe |
| Publisher | : Cold Spring Harbor Perspective |
| Total Pages | : 0 |
| Release | : 2012 |
| Genre | : Medical |
| ISBN | : 9781936113446 |
Alzheimer disease causes the gradual deterioration of cognitive function, including severe memory loss and impairments in abstraction and reasoning. Understanding the complex changes that occur in the brain as the disease progressesincluding the accumulation of amyloid plaques and neurofibrillary tanglesis critical for the development of successful therapeutic approaches. Written and edited by leading experts in the field, this collection from Cold Spring Harbor Perspectives in Medicine includes contributions covering all aspects of Alzheimer disease, from our current molecular understanding to therapeutic agents that could be used to treat and, ultimately, prevent it. Contributors discuss the biochemistry and cell biology of amyloid -protein precursor (APP), tau, presenilin, -secretase, and apolipoprotein E and their involvement in Alzheimer disease. They also review the clinical, neuropathological, imaging, and biomarker phenotypes of the disease; genetic alterations associated with the disorder; and epidemiological insights into its causation and pathogenesis. This comprehensive volume, which includes discussions of therapeutic strategies that are currently used or under development, is a vital reference for neurobiologists, cell biologists, pathologists, and other scientists pursuing the biological basis of Alzheimer disease, as well as investigators, clinicians, and students interested in its pathogenesis, treatment, and prevention.
| Author | : Shuvendu Sen |
| Publisher | : Simon and Schuster |
| Total Pages | : 311 |
| Release | : 2017-10-24 |
| Genre | : Health & Fitness |
| ISBN | : 0757319955 |
Who among us is not affected by issues such as stress, depression, personality and behavioral changes, agitation, hypertension or high cholesterol—to name a few? Did you know that these are some of the cognitive and biological deficiencies that are associated with Alzheimer's? It is estimated that 5.4 million people in the U.S. are afflicted with Alzheimer's disease. In its capacity to completely destroy personalities, relationships and daily living, we cannot afford to continue thinking of it as a private disease. Alzheimer's is a family problem—ruthless in its scope and spread. And despite relentless trials and research studies, scientists have not found a drug to control it. Even worse, there isn't even a fully reliable diagnostic test for it. Alzheimer's disease has become a gigantic specter that looms before all of us as we age, and it is advancing unimpeded. Today we know that contributing factors and symptoms (such as stress and hypertension) can be alleviated with holistic, alternate management approaches—like meditation, yoga, music therapy and virtual reality therapy. Research studies from Harvard Medical School, Johns Hopkins University and Mayo Clinic, among many others, have demonstrated the comprehensive benefits of yoga and meditation on various aspects of the human mind—and when you think about it, that's where Alzheimer's disease develops—in the mind. But, how can meditation and yoga stop or even reverse the course of Alzheimer's? They set the mind on an inward journey where the risk factors that precipitate the disease are formed. This bridging of the old and new creates an imperative paradigm shift in our perspective toward Alzheimer's disease management. Why Buddha Never Had Alzheimer's is precisely what is needed to cause a drastic and necessary revolution in medical care.
